SCHEMBL5308451

SCHEMBL5308451

CN1CCN(c2cc(F)cc3c2OC(C(=O)Nc2ccc(N4CCOCC4)cc2)CC3)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 9/20 0.78
▸ KCNH2 Q12809 1/20 0.78
▸ RAD52 P43351 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GAA P10253 1/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4250243 0.96 HTR1B (0.71) HTR1BKCNH2RAD52MAPTMEN1
SCHEMBL14529770 0.92 HTR1B (0.66) HTR1BKCNH2RAD52MAPTMEN1
SCHEMBL4247598 0.91 HTR1B (0.65) HTR1BKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5308358 0.90 HTR1B (0.79) HTR1BKCNH2RAD52ALDH1A1MAPT
SCHEMBL4597945 0.90 HTR1B (0.66) HTR1BKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5311017 0.90 HTR1B (0.66) HTR1BKCNH2ALDH1A1KDM4EMAPT
SCHEMBL5309015 0.89 HTR1B (0.65) HTR1BKCNH2RAD52ALDH1A1KDM4E
SCHEMBL4246690 0.89 HTR1B (0.62) HTR1BKCNH2ALDH1A1KDM4EMAPT
SCHEMBL4248665 0.89 HTR1B (0.62) HTR1BKCNH2ALDH1A1KDM4EMAPT
SCHEMBL4247047 0.88 HTR1B (1.00) HTR1BKCNH2RAD52ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO claimed
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 — — WO disclosed
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO disclosed
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO disclosed
Send feedback